Clinical Evaluation of the Safety and Efficacy of Trifluridine/Tipiracil in the Treatment of Advanced Gastric/Gastroesophageal Junction Adenocarcinoma: Evidence to Date

Trifluridine/tipiracil or TAS-102 (Taiho Oncology, Lonsurf(®), Princeton, NJ, USA) is a combination tablet of trifluridine, a thymidine-based nucleoside analog, and tipiracil, a thymidine phosphorylase inhibitor, in a 1:0.5 molar ratio. This drug was first approved for use in metastatic colorectal c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wheelden, Megan, Yee, Nelson S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398745/
https://www.ncbi.nlm.nih.gov/pubmed/32801768
http://dx.doi.org/10.2147/OTT.S216598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398745/
https://www.ncbi.nlm.nih.gov/pubmed/32801768
http://dx.doi.org/10.2147/OTT.S216598

Ejemplares similares